share_log

ArriVent BioPharma | 8-K: ArriVent BioPharma Reports Second Quarter 2024 Financial Results

SEC ·  Aug 15 04:12
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more